Sterling Investment Advisors (Pennsylvania)’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-37
| Closed | -$2K | – | 359 |
|
|
2022
Q2 | $2K | Hold |
37
| – | – | ﹤0.01% | 505 |
|
|
2022
Q1 | $3K | Hold |
37
| – | – | ﹤0.01% | 523 |
|
|
2021
Q4 | $7K | Hold |
37
| – | – | ﹤0.01% | 467 |
|
|
2021
Q3 | $10K | Hold |
37
| – | – | ﹤0.01% | 434 |
|
|
2021
Q2 | $9K | Hold |
37
| – | – | ﹤0.01% | 428 |
|
|
2021
Q1 | $11K | Hold |
37
| – | – | ﹤0.01% | 395 |
|
|
2020
Q4 | $9K | Hold |
37
| – | – | ﹤0.01% | 379 |
|
|
2020
Q3 | $9K | Sell |
37
-266
| -88% | -$64.7K | ﹤0.01% | 350 |
|
|
2020
Q2 | $105K | Buy |
303
+253
| +506% | +$87.7K | 0.04% | 156 |
|
|
2020
Q1 | $13K | Hold |
50
| – | – | 0.01% | 301 |
|
|
2019
Q4 | $16K | Hold |
50
| – | – | 0.01% | 313 |
|
|
2019
Q3 | $14K | Buy |
50
+10
| +25% | +$2.8K | 0.01% | 320 |
|
|
2019
Q2 | $21K | Hold |
40
| – | – | 0.01% | 292 |
|
|
2019
Q1 | $20K | Sell |
40
-293
| -88% | -$147K | 0.01% | 294 |
|
|
2018
Q4 | $164K | Buy |
333
+133
| +67% | +$65.5K | 0.1% | 120 |
|
|
2018
Q3 | $183K | Buy |
+200
| New | +$183K | 0.1% | 117 |
|
|
2018
Q2 | – | Sell |
-67
| Closed | -$106K | – | 397 |
|
|
2018
Q1 | $106K | Buy |
+67
| New | +$106K | 0.07% | 139 |
|
|
2017
Q4 | – | Sell |
-200
| Closed | -$72K | – | 353 |
|
|
2017
Q3 | $72K | Hold |
200
| – | – | 0.05% | 153 |
|
|
2017
Q2 | $59K | Hold |
200
| – | – | 0.04% | 169 |
|
|
2017
Q1 | $70K | Hold |
200
| – | – | 0.05% | 151 |
|
|
2016
Q4 | $37K | Buy |
+200
| New | +$37K | 0.03% | 171 |
|